This printed article is located at http://plifereit.listedcompany.com/news.html

News

Change - Announcement Of Appointment Of Non-Executive Director

BackApr 14, 2021
Announcement Title Change - Announcement of Appointment
Date & Time of Broadcast Apr 14, 2021 17:51
Status New
Announcement Sub Title Appointment of Non-Executive Director
Announcement Reference SG210414OTHRMYOI
Submitted By (Co./ Ind. Name) Yong Yean Chau
Designation Director / Chief Executive Officer
Description (Please provide a detailed description of the event in the box below) Appointment of Non-Executive Director
Additional Details
Date Of Appointment 23/04/2021
Name Of Person JOERG AYRLE
Age 52
Country Of Principal Residence Singapore
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process) Mr. Ayrle was nominated by Parkway Holdings Limited, the holding company of Parkway Trust Management Limited ("Company"). The Nominating and Remuneration Committee of the Company ("NRC") has reviewed the qualification and experience of Mr. Ayrle and recommended to the Board the appointment of Mr. Ayrle as a Non-Executive Director of the Company. The Board considered the recommendation of NRC and approved Mr. Ayrle's appointment.
Whether appointment is executive, and if so, the area of responsibility Non-executive
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) Non-Executive Director
Professional qualifications Masters of Business Administration, major in Finance & Controlling, Marketing, Finance Mathematics University of Augsburg, Germany
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries Mr. Ayrle is presently employed under IHH Healthcare Berhad, the substantial unitholder of Parkway Life REIT
Conflict of interests (including any competing business) Nil, except for the directorships held by Mr. Ayrle in the subsidiaries of IHH Healthcare Berhad ("IHH Group").

Should any conflict of interest arise between IHH Group and Parkway Life REIT where IHH Group may have interest in respect of matters involving Parkway Life REIT, Mr. Ayrle shall abstain from voting and recuse from meetings and decisions in respect of such matters.
Working experience and occupation(s) during the past 10 years 1) 1 February 2021 to Present - Group Chief Financial Officer, IHH Healthcare Berhad, Malaysia

2) March 2014 to January 2021 - Group Chief Financial Officer, Thai Union Group PCL, Thailand

3) April 2012 to December 2013 - Chief Financial Officer & Treasurer, Osram Sylvania Inc, USA

4) June 2009 to September 2012 - Global Division Chief Financial Officer, Osram GmbH, Germany
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6)) Yes
Shareholding interest in the listed issuer and its subsidiaries? No
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years) Please refer to Annexure A attached
Present Please refer to Annexure B attached
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner? No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency? No
(c) Whether there is any unsatisfied judgment against him? No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose? No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach? No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part? No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust? No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust? No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity? No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust? No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere? No
Any prior experience as a director of an issuer listed on the Exchange? No
If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange Mr. Ayrle will be attending training on the roles and responsibilities as a director of a listed issuer as prescribed by the Exchange.

Attachments

  1. Annexure A (Size: 51,704 bytes)
  2. Annexure B (Size: 44,896 bytes)

Please read our General Disclaimer & Warning carefully.
Use of this Website constitutes acceptance of the Terms of Website Use.
Copyright © 2024. ListedCompany.com. All Rights Reserved.